Free Trial

Johnson & Johnson (JNJ) Competitors

Johnson & Johnson logo
$191.79 +0.62 (+0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$192.18 +0.39 (+0.20%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM

Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).

Johnson & Johnson vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Intuitive Surgical has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.

In the previous week, Johnson & Johnson had 103 more articles in the media than Intuitive Surgical. MarketBeat recorded 177 mentions for Johnson & Johnson and 74 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.07 beat Johnson & Johnson's score of 1.00 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
53 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive
Johnson & Johnson
107 Very Positive mention(s)
17 Positive mention(s)
30 Neutral mention(s)
5 Negative mention(s)
8 Very Negative mention(s)
Positive

Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$9.15B17.04$2.32B$7.1760.62
Johnson & Johnson$88.82B5.20$14.07B$9.3520.51

Intuitive Surgical presently has a consensus target price of $580.29, suggesting a potential upside of 33.52%. Johnson & Johnson has a consensus target price of $199.59, suggesting a potential upside of 4.07%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.57
Johnson & Johnson
0 Sell rating(s)
8 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.73

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 27.26%. Johnson & Johnson's return on equity of 33.08% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical28.51% 14.56% 12.93%
Johnson & Johnson 27.26%33.08%13.30%

Summary

Intuitive Surgical beats Johnson & Johnson on 9 of the 17 factors compared between the two stocks.

Get Johnson & Johnson News Delivered to You Automatically

Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JNJ vs. The Competition

MetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE Exchange
Market Cap$461.90B$268.09B$6.13B$21.70B
Dividend Yield2.72%2.61%5.73%3.62%
P/E Ratio18.5130.7985.1529.79
Price / Sales5.204.66574.6194.32
Price / Cash14.5514.3637.3924.26
Price / Book6.4619.5812.394.62
Net Income$14.07B$8.49B$3.32B$1.01B
7 Day Performance0.43%-2.02%-0.24%-0.79%
1 Month Performance8.68%2.96%9.56%0.25%
1 Year Performance16.75%-5.24%71.67%11.51%

Johnson & Johnson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
4.8507 of 5 stars
$191.79
+0.3%
$199.59
+4.1%
+16.3%$461.90B$88.82B18.51138,100Trending News
Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
ISRG
Intuitive Surgical
4.9209 of 5 stars
$436.79
+1.7%
$584.76
+33.9%
-9.0%$157.01B$9.15B61.0915,638Trending News
Upcoming Earnings
Analyst Forecast
Short Interest ↑
Analyst Revision
MRNA
Moderna
4.2364 of 5 stars
$26.95
+0.4%
$41.81
+55.2%
-51.6%$10.54B$3.06B-3.585,800
NVAX
Novavax
3.9855 of 5 stars
$8.68
+4.1%
$12.33
+42.2%
-29.3%$1.42B$682.16M3.831,990
ABBV
AbbVie
4.6969 of 5 stars
$231.77
+0.6%
$231.90
+0.1%
+18.0%$409.74B$56.33B110.4555,000Trending News
Analyst Forecast
Options Volume
Analyst Revision
BRK.B
Berkshire Hathaway
2.1148 of 5 stars
$492.13
+0.6%
$575.00
+16.8%
+7.2%$1.06T$371.43B16.89392,400
LLY
Eli Lilly and Company
4.9812 of 5 stars
$822.39
-1.3%
$948.06
+15.3%
-9.6%$778.93B$45.04B53.7947,000Trending News
Analyst Upgrade
Analyst Revision
MRK
Merck & Co., Inc.
4.9993 of 5 stars
$85.59
-0.5%
$105.00
+22.7%
-24.6%$213.92B$63.62B13.2075,000Trending News
Analyst Forecast
Analyst Revision
PFE
Pfizer
4.9605 of 5 stars
$24.81
+0.1%
$28.35
+14.3%
-17.2%$141.14B$63.63B13.2081,000Positive News
Dividend Announcement
Analyst Revision
PG
Procter & Gamble
4.7093 of 5 stars
$147.33
-1.6%
$172.21
+16.9%
-15.1%$345.12B$84.28B22.65109,000Positive News
Dividend Announcement
XOM
Exxon Mobil
4.9343 of 5 stars
$111.99
+1.1%
$126.05
+12.6%
-7.2%$477.77B$329.39B15.9261,000Trending News
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners